APA (7th ed.) Citation

Wixner, J., Westermark, P., Ihse, E., Pilebro, B., Lundgren, H., & Anan, I. (2019). The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition. Amyloid, 26, 39. https://doi.org/10.1080/13506129.2019.1593133

Chicago Style (17th ed.) Citation

Wixner, Jonas, Per Westermark, Elisabet Ihse, Björn Pilebro, Hans-Erik Lundgren, and Intissar Anan. "The Swedish Open-label Diflunisal Trial (DFNS01) on Hereditary Transthyretin Amyloidosis and the Impact of Amyloid Fibril Composition." Amyloid 26 (2019): 39. https://doi.org/10.1080/13506129.2019.1593133.

MLA (9th ed.) Citation

Wixner, Jonas, et al. "The Swedish Open-label Diflunisal Trial (DFNS01) on Hereditary Transthyretin Amyloidosis and the Impact of Amyloid Fibril Composition." Amyloid, vol. 26, 2019, p. 39, https://doi.org/10.1080/13506129.2019.1593133.